Who is sponsoring NCT03021538?

NCT03021538 is sponsored by The Cleveland Clinic.

What drugs are being tested in NCT03021538?

Interventions in NCT03021538: Extracorporeal Membrane Oxygenation, Cardiopulmonary Bypass.

What condition does NCT03021538 study?

NCT03021538 studies Lung Transplant; Complications.

Is NCT03021538 still recruiting?

NCT03021538 is currently terminated. Last updated 24 March 2020.

Are results published for NCT03021538?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-03-24 · How we verify

NCT03021538: BELT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bypass vs. Ecmo in Lung Transplantation (BELT)

Terminated Results posted Last updated 24 March 2020

What this trial tests

trial testing Extracorporeal Membrane Oxygenation in Lung Transplant; Complications in 13 participants. Terminated before completion.

Timeline

17 April 2017

Primary endpoint
24 January 2019

24 January 2019

Quick facts

Lead sponsor	The Cleveland Clinic
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	13
Start date	17 April 2017
Primary completion	24 January 2019
Estimated completion	24 January 2019
Sites	1 location across United States

Drugs / interventions tested

Extracorporeal Membrane Oxygenation
Cardiopulmonary Bypass

Conditions studied

Lung Transplant; Complications — all drugs for Lung Transplant; Complications →

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Lung Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Need for Blood Transfusion Primary · 72 hours after surgery

Number of pRBC transfusion that resulted due to postoperative bleeding

Group	Value	95% CI
Cardiopulmonary Bypass	4.8	± 6.1
Extracorporeal Membrane Oxygenation	6	± 6.2

Sponsor's own description

This study seeks to compare outcomes of 2 different methods of cardiopulmonary support during lung transplant surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Extracorporeal Membrane Oxygenation

Trials testing the same drug.

NCT05387902 — Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry · completed
NCT04144660 — "Treatment Use of ECMO In Pregnancy or Peripartum Patient." · completed
NCT03979222 — Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure · completed

Other recruiting trials for Lung Transplant; Complications

Currently open trials in the same condition.

NCT06399302 — Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes · recruiting
NCT05836922 — Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Fail · recruiting
NCT04469842 — Early Use of Long-acting Tacrolimus in Lung Transplant Recipients · EARLY_PHASE1 · recruiting
NCT05526950 — Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb) · NA · recruiting
NCT05050955 — AlloSure Lung Assessment and Metagenomics Outcomes Study · active not recruiting

Other The Cleveland Clinic trials

Trials by the same sponsor.

NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03021538 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
Last refreshed: 24 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03021538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing